TCL Archive President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20% February 2, 1990
TCL Archive From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas January 27, 2012
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Public Health Service: Scientific Papers Become “Deliverables” In Own RFP October 3, 1997
